Gabor patch technology is a non-invasive, patient-specific treatment based on visual stimulation and facilitation of neural connections responsible for vision. The treatment improved BCVA in Stargardt patients. Mean BCVA, for the 10 eyes, has raised from 0.81 (+- 0.17) logMar to 0.49 (+-0.07) logMar. Mean ETDRS’ chart lines improvement has been 3.18 +-2.05. This improvement appears to be retained for at least 12 months after treatment, consistent with the disease progression.

Improving visual activity using Gabor patch technology in Stargardt disease: a retrospective study

Gallenga CE
Primo
Conceptualization
;
Parmeggiani F
Secondo
Validation
;
Perri P.
Ultimo
Supervision
2018

Abstract

Gabor patch technology is a non-invasive, patient-specific treatment based on visual stimulation and facilitation of neural connections responsible for vision. The treatment improved BCVA in Stargardt patients. Mean BCVA, for the 10 eyes, has raised from 0.81 (+- 0.17) logMar to 0.49 (+-0.07) logMar. Mean ETDRS’ chart lines improvement has been 3.18 +-2.05. This improvement appears to be retained for at least 12 months after treatment, consistent with the disease progression.
2018
Mincarelli, C; Gallenga, Ce; Colangelo, L; Lobefalo, L; Di Carlo, Pg; Nuri, M; Parmeggiani, F; Perri, P.
File in questo prodotto:
File Dimensione Formato  
ECOP-09-00273.pdf

accesso aperto

Descrizione: Articolo principale
Tipologia: Post-print
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 611.32 kB
Formato Adobe PDF
611.32 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2402667
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact